We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.
An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
1.The PRISM-PLUS Study Investigators. Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction. N Engl J Med1998;338: 1488–96.CrossRefGoogle Scholar
2
2.The PARAGON Investigators. International randomized controlled trial of lamifoban (a platelet glycoprotein IIb/IIIa inhibitor), heparin, or both in unstable angina. Circulation1994;97:2386–95.Google Scholar